Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New developments in hematopoietic stem cell transplantation].

A Gratwohl1

  • 1Abteilung für Hämatologie, Departement Innere Medizin, Kantonsspital, Basel. hematology@uhbs.ch

Therapeutische Umschau. Revue Therapeutique
|December 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016
Same author

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Hematopoietic stem cell transplantation is a key therapy for various blood disorders. Advances allow broader patient eligibility, integrating personalized risk profiles for optimized treatment timing and procedures.

Area of Science:

  • Hematology
  • Transplant Medicine
  • Oncology

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a standard therapeutic approach.
  • Transplants utilize bone marrow, peripheral blood, or cord blood stem cells.
  • Established indications include leukemias, lymphoproliferative disorders, aplastic anemia, and congenital bone marrow disorders.

Purpose of the Study:

  • To review current hematopoietic stem cell transplantation practices.
  • To highlight advancements expanding patient eligibility and treatment strategies.
  • To discuss the future potential of HSCT as a model for other organ transplants.

Main Methods:

  • Review of established and emerging hematopoietic stem cell transplantation techniques.
  • Analysis of indications for allogeneic and autologous transplants.

Related Experiment Videos

  • Discussion of novel approaches like reduced intensity conditioning and donor lymphocyte infusions.

    • Main Results:

    • Hematopoietic stem cell transplantation is indicated for a range of hematologic malignancies and non-malignant disorders.
    • Allogeneic transplants are used for leukemias and bone marrow failures, while autologous transplants treat solid tumors and autoimmune diseases.
    • Reduced intensity conditioning and selective donor lymphocyte infusions expand HSCT applicability to older patients and those with comorbidities.

    Conclusions:

    • Hematopoietic stem cell transplantation is a versatile and evolving therapy.
    • Personalized risk assessment, not just diagnosis and age, guides procedure selection and timing.
    • HSCT may serve as a paradigm for future regenerative medicine and organ transplantation strategies.